@openevidence.bsky.social
Next, Mario Aquilar interviews Zachary Ziegler from @openevidence.bsky.social “OpenEvidence won the hearts of doctors. Now what?” ZZ: Evidence is the core foundation of medicine. Doctors can input a lot of data and get really personalized medicine. The website is free. #STATBreakthrough
Join STAT correspondent Mario Aguilar and @openevidence.bsky.social to discuss how it disrupted legacy medical reference tools by winning over hundreds of thousands of clinicians with AI-powered search — and where the company goes next.
@openevidence.bsky.social Won the Hearts of Doctors. Now What? In just a few years, it has drawn thousands of clinicians to its AI-powered search, upending decades-old reference tools. Now that it’s won over doctors, where does it go next? Join Us: statnews.com/stat-summit-... #STATBreakthrough
STAT Breakthrough Summit West 2026 - San Francisco, May 19
STAT Breakthrough Summit West on May 19, 2026 in San Francisco is your chance to hear from industry leaders on the latest trends at the intersection of science, medicine, and technology.
statnews.com
I am so excited about the opportunity to work with ACOG to better understand and support clinical knowledge requirements in woman's health!
ACOG@acog.org · 3mo agoWe’re thrilled to announce a strategic collaboration between ACOG and OpenEvidence. Our clinical guidance is now integrated into the platform, expanding clinician access to evidence-based ob-gyn guidance to support their point-of-care decision making. Read the press release: https://bit.ly/4eqAroS
Thanks to noted futurist Jeff Goldsmith for his lovely and insightful review of A GIANT LEAP in today's Health Affairs journal. "... an island of calm and thoughtful commentary in the midst of an exhausting wave of hype.... Highly recommended." www.healthaffairs.org/content/fore...
A Voice Of Calm Amidst The AI Hype Storm | Health Affairs Forefront
Jeff Goldsmith reviews “A Giant Leap,” a thoughtful new book about how artificial intelligence is transforming health care, by Robert Wachter.
healthaffairs.org
Excited to share our team's new partnership with @openevidence.bsky.social and the Rwanda Biomedical Centre to build AI clinical decision support tools for resource-limited settings. Rwandan clinicians will help design evidence-based technology, driving better care where it's needed most.
45 Rwandan Clinicians Are Helping Shape Medical AI for Low-Resource Setting
Partnership adapting OpenEvidence clinical decision support AI for Rwanda, with 45 clinicians testing and guiding customization.
resolvetosavelives.org
Inspired by a @nejm.org piece by Drs Brian Garibaldi and Steven Russell, I add my two cents on the physical examination. Because limitations notwithstanding, it still matters. blogs.nejm.org/hiv-id-obser...
What Use Is the Physical Examination in Current Medical Practice?
Share Tweet Pin Mail SMS A very interesting, quite scholarly perspective appeared in the NEJM last month called, “Strategies to Reinvigorate the Bedside Clinical ...
blogs.nejm.org
The NCCN's Clinical Practice Guidelines in Oncology to be integrated into @openevidence.bsky.social's medical AI platform so clinicians can access trusted, evidence-based cancer care recommendations for decision-making support via natural language search. ➡️https://ow.ly/QqaK50Xr3w4
New on The Tech Glow Up from #hlth2025 40% of doctors use it. Daily. 🩺🤖 @OpenEvidence = ChatGPT for clinicians, built by Harvard AI researchers who got tired of generic search 40M papers + 20K new studies/day = knowledge overload solved! @openevidence.bsky.social
@travizack.bsky.social and Varun from OE talk AI and the future of medical information on the STAT-AI podcast: open.spotify.com/episode/121y...
EP10 Travis Zack MD, PhD and Varun Mangalick BS, Open Evidence
STAT AI: An Emergency Medicine Podcast · Episode
open.spotify.com
Happy first day! To all interns, residents, fellows, and new attendings. We are building specialty specific learning communities at OE. If you are interested in joining peers and learning together with Openevidence, shoot us an email at md_community@openevidence.com
Dr. Atul Butte was laid to rest today. His large shoulders and larger vision have been foundational to all AI can and will accomplish in healthcare. His family is requesting those interested to please consider supporting research on mpnst here: giving.ucsf.edu/fund/maligna...
Your gift can ignite discovery and inspire cures
What are you passionate about? Unlocking the brain’s mysteries? Battling health inequity? Donate to UCSF today, and together we will build a healthier tomorrow.
giving.ucsf.edu
👋 Our editors are on-site at #ASCO25, Chicago. We’re excited to be part of this gathering of global cancer experts—come & meet us. ‘Contact the Editor’ details below, in-thread 🧵 @ascocancer.bsky.social
Hello from the City of Lakes! We’re thrilled to welcome thousands of members of the ob-gyn community to the 2025 Annual Clinical & Scientific Meeting. From the heart of the Midwest, we’re kicking off a weekend of connection, learning, and inspiration. Share the excitement using #ACOG2025!
As for the safety, I asked @openevidence.bsky.social which is a chatbot trained on the professional medical literature. The current thinking is that it is not ready for primetime. www.openevidence.com/ask/2ca4fd30...
OpenEvidence
The leading medical information platform.
openevidence.com
we are now offering free CME credits just by OE in yuour normal practice: www.openevidence.com/announcement...
OpenEvidence - CME has arrived on OpenEvidence
CAMBRIDGE, MA, April 2, 2025 – We are thrilled to announce that CME is now available for free on OpenEvidence! Verified NPI users can now earn AMA PRA Category 1 Credits™.
openevidence.com
So thrilled to welcome this extraordinary group of 64 young physicians to @UCSF and @UCSFimresidency. A great day! (UCPC=UCSF Health-based primary care program; SFGH=San Francisco General-based primary care; PSTP=physician-scientist training program) @UCSFIMChiefs @UCSFDOM
www.openevidence.com/announcement...
OpenEvidence - OpenEvidence and NEJM Group, publisher of the New England Journal of Medicine, sign content agreement: Clinicians using OpenEvidence benefit from content sourced from NEJM Group journal...
CAMBRIDGE, MA, February 19, 2025 – OpenEvidence, the fastest-growing platform for doctors, has signed a multi-year content agreement with NEJM Group, publisher of the New England Journal of Medicine (...
openevidence.com
@travizack.bsky.social and Varun from OE talk AI and the future of medical information on the STAT-AI podcast: open.spotify.com/episode/121y...
EP10 Travis Zack MD, PhD and Varun Mangalick BS, Open Evidence
STAT AI: An Emergency Medicine Podcast · Episode
open.spotify.com
www.openevidence.com/ask/88013027...
OpenEvidence - What is the evidence for cabozatinib in neuroendocrine tumors
The evidence for the use of cabozantinib in neuroendocrine tumors (NETs) is supported by several clinical studies and trials. A pivotal study published in The New England Journal of Medicine evaluated...
openevidence.com
NEJM.org@nejm.org · last yr.Most patients with extrapancreatic neuroendocrine tumors or pancreatic neuroendocrine tumors eventually have disease progression with available therapies, and new treatments are needed. Research findings are summarized in a new Quick Take video. youtu.be/v4VemREn1QM #MedSky #Oncology
Some background on current limited TX options: www.openevidence.com/ask/a94c01ac... However, there is a recently opened clinical trial for this rare disease clinicaltrials.gov/study/NCT061... @jerryclee.bsky.social
ClinicalTrials.gov
clinicaltrials.gov
NEJM.org@nejm.org · last yr.HLH, a cytokine-mediated hyperinflammation syndrome, causes fever, pancytopenia, and hemophagocytosis and is often fatal. Antiinflammatory agents, etoposide, and interferon-γ antibody are the main treatments. Learn more in a new review: nej.md/40Jps19 #MedSky #Oncology
Some mechanistic background: www.openevidence.com/ask/07ad3d33...
OpenEvidence - How are cart created and how could that lead to oncogenesis
Chimeric antigen receptor (CAR) T-cells are created through a multi-step process involving T-cell apheresis, CAR transduction, and expansion of the transduced T cells. Initially, T cells are collected...
openevidence.com
NEJM.org@nejm.org · last yr.A woman with multiply relapsed multiple myeloma had complete remission with cilta-cel, but a low-grade T-cell lymphoma soon developed in the GI tract that contained an insertion of the CAR construct disrupting expression of p53. Read the Brief Report: nej.md/40Yq3gO #MedSky #Oncology
A short review of where we were at prior to this trial www.openevidence.com/ask/1e95f6d9...
OpenEvidence - What are current treatment options for hereditary angioedema
Hereditary angioedema (HAE) is managed through a combination of on-demand treatments for acute attacks and prophylactic therapies to prevent attacks. The treatment approach depends on the type of HAE,...
openevidence.com
NEJM.org@nejm.org · last yr.In a new phase 2 trial, researchers evaluated the efficacy of a gene-editing therapy, NTLA-2002, in preventing angioedema attacks in patients with hereditary angioedema. Full trial results and Plain Language Summary: nej.md/4heR7hT #MedSky #Oncology
In a new phase 2 trial, researchers evaluated the efficacy of a gene-editing therapy, NTLA-2002, in preventing angioedema attacks in patients with hereditary angioedema. Full trial results and Plain Language Summary: nej.md/4heR7hT #MedSky #Oncology
www.openevidence.com/ask/55b54926...
OpenEvidence - What is the evidence for alcohol use and cancer
The relationship between alcohol use and cancer is well-established in the medical literature. Alcohol consumption is causally linked to several types of cancer, including cancers of the oral cavity, ...
openevidence.com
The Lancet@thelancet.com · last yr.Associations between alcohol consumption and cancer are scientifically well established, but the public are often unaware of the links. Should alcohol carry cancer warning labels? On #WorldCancerDay, a new World Report explores this question: tinyurl.com/ytfhkry9
As a primary care doctor & clinical informatician, I love using @openevidence.bsky.social during my clinic visits to review latest guidelines with patients & sources. I strongly believe this practice helps build stronger therapeutic relationship with the doctor + AI assisted CDS. #CI=AI
Other prior trials looking at the pros and cons of bridging AC peri-procedures www.openevidence.com/ask/67491f3f...
OpenEvidence - What are some trials that evaluated the pros and cons of ceasing anticoagulation prior to procedures
Several trials have evaluated the pros and cons of ceasing anticoagulation prior to procedures, particularly focusing on the use of bridging anticoagulation. 1.
openevidence.com
NEJM.org@nejm.org · 2y agoIn the POPular PAUSE TAVI trial, researchers assessed the efficacy and safety of continuing oral anticoagulation, as compared with interrupting it, during transcatheter aortic-valve implantation (TAVI). Full trial results and Plain Language Summary: nej.md/3XllHys #MedSky #CardioSky
